Healthcare >> CEO Interviews >> September 13, 2002
NICHOLAS L. TETI has served as Chairman and Chief Executive Officer
since July 2002 and joined INAMED in August 2001 as President, Chief
Executive Officer and a member of the Board of Directors. He has over 25
years of management, operations and marketing experience in the
pharmaceuticals industry. From January 1997 until December 2000, Mr.
Teti was President, Chief Executive Officer and Chief Operating Officer
of DuPont Pharmaceuticals Company, a company with $1.6 billion in sales
in 1999. He spent 25 years at DuPont and DuPont Merck, which included a
number of senior management positions. Several of these assignments were
in leadership roles of Dupont's global pharmaceuticals business units.
From January 2001 until July 2001, he was President and Director of
Yamanouchi USA Inc., a division of Yamanouchi Pharmaceuticals Co., where
he was responsible for establishing its US business. Mr. Teti holds an
MBA in Health Care Administration and a BA in Economics from St.
Joseph's University. Profile
TWST: Could we begin with a brief historical sketch and overview ofINAMED?
Mr. Teti: I joined Inamed in August 2001 as the CEO & President. One of
the first things that I addressed was